Evaluation of 6-substituted coumarins as SARS-CoV-2 main protease inhibitors: enzymatic, cellular, and computational insights
Year: 2026
Type: article
Abstract: The SARS-CoV-2 main protease (M pro ) plays a crucial role in viral replication, making it an attractive target for antiviral drug development.
Source: RSC Advances
DOI: 10.1039/d6ra07298d
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,042
Funders: Ministry of Oceans and Fisheries, Ministry of Food and Drug Safety, Ministry of Health and Welfare, Korea Institute of Science and Technology, Korea Health Industry Development Institute, National Research Foundation of Korea, Korea Institute of Marine Science and Technology promotion, Ministry of Science and ICT, South Korea, Advanced Research Projects Agency
OpenAlex ID: W7220404958
